Citi Pharma Limited (PSX:CPHL)

Citi Pharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	17,804	19,184	6,511	4,875	7,457	-
Market Cap Growth	-24.91%	194.63%	33.55%	-34.62%	-	-
Enterprise Value	20,355	20,807	6,236	4,443	5,627	-
Last Close Price	77.93	80.81	25.42	17.15	26.24	-
PE Ratio	17.13	21.51	7.81	7.41	11.41	-
Forward PE	18.55	6.34	6.34	6.34	-	-
PS Ratio	1.26	1.46	0.53	0.39	0.76	-
PB Ratio	1.67	1.77	1.16	0.91	1.58	-
P/TBV Ratio	1.67	1.77	1.16	0.91	1.58	-
P/FCF Ratio	-	-	8.46	-	-	-
P/OCF Ratio	-	-	4.87	-	-	-
EV/Sales Ratio	1.44	1.58	0.50	0.36	0.57	-
EV/EBITDA Ratio	8.94	11.78	4.65	3.53	5.28	-
EV/EBIT Ratio	9.82	12.97	5.17	3.81	5.66	-
EV/FCF Ratio	-19.83	-	8.11	-	-	-
Debt / Equity Ratio	0.53	0.27	0.26	0.34	0.20	0.07
Debt / EBITDA Ratio	2.49	1.66	1.08	1.46	0.88	0.50
Debt / FCF Ratio	-	-	1.89	-	-	-
Net Debt / Equity Ratio	0.24	0.13	0.01	0.05	-0.22	-0.63
Net Debt / EBITDA Ratio	1.13	0.77	0.03	0.21	-0.99	-4.36
Net Debt / FCF Ratio	-2.48	-2.89	0.05	-0.20	1.14	52.65
Asset Turnover	0.84	0.88	1.16	1.37	1.34	1.29
Inventory Turnover	3.01	3.12	3.72	5.06	6.82	6.02
Quick Ratio	0.72	0.66	0.68	0.80	1.15	1.92
Current Ratio	1.21	1.30	1.36	1.48	1.86	2.45
Return on Equity (ROE)	13.00%	10.81%	15.14%	13.05%	14.40%	13.16%
Return on Assets (ROA)	7.75%	6.71%	7.03%	8.06%	8.49%	7.96%
Return on Invested Capital (ROIC)	10.01%	11.81%	13.88%	17.27%	23.24%	26.99%
Return on Capital Employed (ROCE)	18.90%	14.40%	20.60%	21.10%	19.40%	12.20%
Earnings Yield	5.85%	4.65%	12.80%	13.50%	8.77%	-
FCF Yield	-5.77%	-2.45%	11.82%	-26.33%	-12.38%	-
Dividend Yield	4.49%	4.33%	12.78%	14.57%	-	-
Payout Ratio	76.48%	82.94%	68.53%	-	47.66%	-
Buyback Yield / Dilution	-0.13%	-	-	-0.70%	-21.65%	-88.38%
Total Shareholder Return	4.30%	4.33%	12.78%	13.87%	-21.65%	-88.38%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.